Immuneering Corporation IMRX
3.79 USD -0.06 (-1.56%)
At closeNov 11, 2026, 7:50 PM EST
3.85 +0.06 +1.58%
After hours · Nov 11, 7:50 PM ET
3.79 Day range 3.95
3.37 52-week range 8.33
- YTD
- -42.40%
- 1 year
- -43.77%
IMRX revenue history
Revenue is income from the company’s ordinary business activities.
0 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 0 | 0 | Not meaningful |
| FY 2024 | 2024-12-31 | 0 | 0 | Not meaningful |
| FY 2023 | 2023-12-31 | 0 | -316,952 | -100.00% |
| FY 2022 | 2022-12-31 | 316,952 | -1,763,009 | -84.76% |
| FY 2021 | 2021-12-31 | 2,079,961 | -231,574 | -10.02% |
| FY 2020 | 2020-12-31 | 2,311,535 | 391,826 | 20.41% |
| FY 2019 | 2019-12-31 | 1,919,709 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-07T06:00:43.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.